Key result
Macrophages play a central role in both the inflammatory response and extracellular matrix remodeling following myocardial infarction, presenting potential therapeutic targets for preventing heart failure.
Why the study?
Despite advances in myocardial infarction therapies, morbidity and mortality remain high, prompting interest in targeting inflammation and extracellular matrix remodeling, particularly macrophages, to prevent heart failure.
Understanding the dynamic role of macrophages in extracellular matrix remodeling post-myocardial infarction may reveal new therapeutic targets to prevent heart failure.
Answers are grounded in this paper and cite their sources.
Macrophage targeting post-MI remains investigational; leaves open whether modulating inflammation or remodeling reduces heart failure risk.
Myocardial infarction is the most common form of acute cardiac injury attributing to heart failure. While there have been significant advances in current therapies, mortality and morbidity remain high. Emphasis on inflammation and extracellular matrix remodeling as key pathological factors has brought to light new potential therapeutic targets including macrophages which are central players in the inflammatory response following myocardial infarction. Blood derived and tissue resident macrophages exhibit both a pro- and anti-inflammatory phenotype, essential for removing injured tissue and facilitating repair, respectively. Sustained activation of pro-inflammatory macrophages evokes extensive remodeling of cardiac tissue through secretion of matrix proteases and activation of myofibroblasts. As the heart continues to employ methods of remodeling and repair, a destructive cycle prevails ultimately leading to deterioration of cardiac function and heart failure. This review summarizes not only the traditionally accepted role of macrophages in the heart but also recent advances that have deepened our understanding and appreciation of this dynamic cell. We discuss the role of macrophages in normal and maladaptive matrix remodeling, as well as studies to date which have aimed to target the inflammatory response in combatting excessive matrix deposition and subsequent heart failure.
No takes yet. Share an insight, caveat, or question.
O’Rourke et al. (2019) conducted a review in Myocardial Infarction and Heart Failure. Macrophage immunomodulation and ECM targeting was evaluated. Macrophages play a central role in both the inflammatory response and extracellular matrix remodeling following myocardial infarction, presenting potential therapeutic targets for preventing heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: